Laser vision correction procedures differ in a number of ways, but conventional treatments use the same formula to treat every person with the same optical prescription. The Allegretto Wave, however, was conceived from the start to perform custom treatments and incorporates wavefront technology principles into each procedure while adjusting each treatment to the patient's individual cornea.
In addition, the Allegretto Wave is the fastest laser system available in the U.S. today, and allows the surgeon to finely sculpt the patient's new vision with precise accuracy. This laser also features an ultra-fast eye-tracking system to follow eye movement during the procedure.
This high-speed tracker is a key component of the system's unique PerfectPulse Technology, developed to accurately control the energy level and exact placement of every laser pulse. Understanding that all eyes are not the same, the Allegretto Wave takes into consideration each patient's individual corneal steepness and automatically compensates for laser energy that can be lost in the periphery of the cornea due to the eye's natural shape. By doing so, the Allegretto Wave specifically addresses spherical aberrations that can potentially cause glare and may distort night vision.
FDA clinical trials included more than 1,000 eyes and demonstrated that 93 percent of all patients saw at least as well or better without glasses after the Allegretto Wave treatment than they could with glasses or contacts beforehand. In fact, initial treatment results were so accurate that fewer than 5 percent needed enhancements and more than 60 percent of nearsighted patients achieved 20/16 vision or better.
Wake Forest University Eye Center invested in the Allegretto Wave because we believe our patients deserve the best vision possible. In fact, the Allegretto Wave was granted clearance for the widest approval range ever initially granted to a new laser system because it allows even patients with high myopia and even hyperopia to benefit from the promise of a custom treatment.
FDA clinical trials included more than 1,000 eyes and demonstrated that 93 percent of all patients saw at least as well or better without glasses after the Allegretto Wave treatment than they could with glasses or contacts beforehand. In fact, initial treatment results were so accurate that fewer than 5 percent needed enhancements and more than 60 percent of nearsighted patients achieved 20/16 vision or better.
